Feasibility of Spinal Manual Therapy Interventions for a Future Clinical Study of Back Pain

Feasibility of Blinding Spinal Manual Therapy Interventions for a Trial Assessing Management of Primary Care Patients With Back Pain: the SALuBRITY Blinding Feasibility Randomised Controlled Trial

This study aims to compare two different spinal manual therapy interventions of the back to determine if they are viable and acceptable for a future study investigating the treatment of patients with back pain. The two proposed spinal manual therapy interventions are widely used in the fields of chiropractic, physical therapy, osteopathy, and manual medicine to treat back pain and improve function. This is a randomized study, meaning that participants are randomly assigned (like tossing a coin) to one of two manual spinal therapy interventions.

Study Overview

• Status: Completed
• Conditions: Back Pain; Back Pain With Radiation; Back Pain, Low
• Intervention / Treatment: Procedure: Active spinal manual therapy protocol; Procedure: Control spinal manual therapy protocol

Detailed Description

Clinical trials of spinal manual therapy interventions for back pain and back-related leg pain face methodological challenges regarding the design of effective sham control ('control' hereafter) and blinding of the assigned interventions. Although the assessment of blinding is often neglected in the field of manual medicine, the implementation of high-quality trials of spinal manual therapy interventions warrants formal evaluation of blinding feasibility among participants and outcome assessors to advance randomized clinical trial methods and design.

The objectives of this blinding feasibility trial are:

1. To assess the feasibility of blinding participants, with or without experience of spinal manual therapy or current low back pain, randomly allocated to an active or control spinal manual therapy intervention protocol.
2. To assess the feasibility of blinding managing clinicians (non-treating clinicians or outcome assessors) within the randomised trial context.
3. To examine the impact of spinal manual therapy experience in the past 3 months (Yes vs No) and presence of low back pain during the past four weeks (average intensity ≤2 versus ≥3 out of 10) on the feasibility of participant and managing clinician blinding.
4. To explore factors contributing to participant and managing clinician perceptions about the assigned intervention (active versus control) using a qualitative thematic analysis.

• Study Type: Interventional
• Enrollment (Actual): 81
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Switzerland
  • Zürich, Switzerland, 8008
    • Balgrist University Hospital and CHIROMED Praxis im Seefeld

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Aged 18 years or older
• With or without experience of spinal manual therapy
• With or without experience of current low back pain

Exclusion Criteria:

• Serious spinal pathology (e.g. spinal fracture, cancer or infection)
• History of lumbar spine surgery
• Currently under care or in consultation with a specialist, chiropractor, physiotherapist, or osteopath for current back pain
• Manual medicine health care provider (i.e., chiropractor, physiotherapist, osteopath, massage therapist, manual medicine trained physician)
• Have a serious comorbidity preventing them from attending the research clinic and receiving the interventions
• Pregnant or breastfeeding status
• Involved in pending litigation related to back pain
• Already participating in another research study related to back pain

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Active spinal manual therapy protocol; (1) Side-lying lumbar spine manipulation, (2) prone lumbar spine mobilization, and (3) prone thoracic spine manipulation.	Procedure: Active spinal manual therapy protocol; The chiropractor will start by (1) placing one hand over L4-L5 or L5-S1 and then will apply a high-velocity, low-amplitude (HVLA) thrust with a therapeutic line of drive. Side-lying lumbar manipulation will be performed bilaterally, with the treating clinician choosing any suitable technique and with or without occurrence of the characteristic audible joint cavitation associated with spine manipulation. The chiropractor will then perform (2) prone lumbar mobilisation by placing the contact hand and applying downward pressure over L4-L5 or L5-S1 with the other hand guiding a manual flexion-distraction piece to apply therapeutic mobilization of the lumbar spine. The chiropractor will deliver (3) a prone thoracic manipulation by placing two hands over the transverse processes of T5-T6 or T6-T7 and applying a HVLA thrust in a posterior-to-anterior direction.
Sham Comparator: Control spinal manual therapy protocol; (1) Control side-lying lumbar spine manipulation, (2) control prone lumbar spine mobilization, and (3) control prone thoracic spine manipulation.	Procedure: Control spinal manual therapy protocol; (1) Control side-lying lumbar manipulation will be operationalised as the application of a low-velocity broad push manoeuvre to the gluteal region following a non-therapeutic line of drive. The chiropractor will then perform (2) control prone lumbar mobilisation, consisting of a non-therapeutic manual manoeuvre involving minimal oscillations (0 to ±2°) of the flexion-distraction piece with light touch over the lumbar spine region, and (3) control prone thoracic mobilisation consisting of two-handed left and right scapula pushes with a nontherapeutic line of drive.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Participant blinding success, as measured by the validated Bang blinding index, immediately after intervention session 1.	The blinding assessment survey item will ask: "Which treatment do you believe you received?" with five response options provided: "Strongly believe I received the genuine treatment," "Somewhat believe I received the genuine treatment," "Somewhat believe I received the control treatment," "Strongly believe I received the control treatment," and "I do not know which treatment I received." Bang BI estimates (between -1 to +1, with 0 indicating satisfactory blinding) can be interpreted as the proportion of correct guesses beyond chance within an intervention arm. For the Bang BI, a score with an absolute value of ≤0.3 (i.e., -0.3 to 0.3) will be deemed compatible with satisfactory blinding, and blinding scenarios will be discussed.	Immediately after intervention session 1 (study day 1)
Participant blinding success, as measured by the validated Bang blinding index, immediately after intervention session 2.	The blinding assessment survey item will ask: "Which treatment do you believe you received?" with five response options provided: "Strongly believe I received the genuine treatment," "Somewhat believe I received the genuine treatment," "Somewhat believe I received the control treatment," "Strongly believe I received the control treatment," and "I do not know which treatment I received." Bang BI estimates (between -1 to +1, with 0 indicating satisfactory blinding) can be interpreted as the proportion of correct guesses beyond chance within an intervention arm. For the Bang BI, a score with an absolute value of ≤0.3 (i.e., -0.3 to 0.3) will be deemed compatible with satisfactory blinding, and blinding scenarios will be discussed.	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Participant blinding success, as measured by the validated James blinding index, immediately after intervention session 1.	The James BI, a modification of the kappa statistic that measures disagreement beyond chance, returns a value between 0 and 1, with 1 equal to all "don't know" responses (complete blinding), 0 equal to all correct responses (complete unblinding), and 0.5 where respondents' responses appear random (50% correct, 50% incorrect).	Immediately after intervention session 1 (study day 1)
Participant blinding success, as measured by the validated James blinding index, immediately after intervention session 2.	The James BI, a modification of the kappa statistic that measures disagreement beyond chance, returns a value between 0 and 1, with 1 equal to all "don't know" responses (complete blinding), 0 equal to all correct responses (complete unblinding), and 0.5 where respondents' responses appear random (50% correct, 50% incorrect).	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Outcome assessor blinding success, as measured by the validated Bang index, immediately after intervention session 1.	Bang BI estimates (between -1 to +1, with 0 indicating satisfactory blinding) can be interpreted as the proportion of correct guesses beyond chance within an intervention arm.	Immediately after intervention session 1 (study day 1)
Outcome assessor blinding success, as measured by the validated Bang index, immediately after intervention session 2.	Bang BI estimates (between -1 to +1, with 0 indicating satisfactory blinding) can be interpreted as the proportion of correct guesses beyond chance within an intervention arm.	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Outcome assessor blinding success, as measured by the validated James index, immediately after intervention session 1.	The James BI measures disagreement beyond chance and returns a value between 0 and 1, with 1 equal to all "don't know" responses (complete blinding), 0 equal to all correct responses (complete unblinding), and 0.5 where respondents' responses appear random (50% correct, 50% incorrect).	Immediately after intervention session 1 (study day 1)
Outcome assessor blinding success, as measured by the validated James index, immediately after intervention session 2.	The James BI measures disagreement beyond chance and returns a value between 0 and 1, with 1 equal to all "don't know" responses (complete blinding), 0 equal to all correct responses (complete unblinding), and 0.5 where respondents' responses appear random (50% correct, 50% incorrect).	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Lumbar spine range of motion, immediately before intervention session 1.	Maximum active total flexion and extension (0 to 100+ degrees) in standing position, measured with a validated mobile phone measuring device. Higher scores represent higher flexibility.	Immediately before intervention session 1 (study day 1)
Lumbar spine range of motion, immediately after intervention session 1.	Maximum active total flexion and extension (0 to 100+ degrees) in standing position, measured with a validated mobile phone measuring device. Higher scores represent higher flexibility.	Immediately after intervention session 1 (study day 1)
Lumbar spine range of motion, immediately before intervention session 2.	Maximum active total flexion and extension (0 to 100+ degrees) in standing position, measured with a validated mobile phone measuring device. Higher scores represent higher flexibility.	Immediately before intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Lumbar spine range of motion, immediately after intervention session 2.	Maximum active total flexion and extension (0 to 100+ degrees) in standing position, measured with a validated mobile phone measuring device. Higher scores represent higher flexibility.	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Self-rated general health, immediately before intervention session 1.	Participants will answer the question "In general, would you say your health is" with five possible ordinal answers: "Excellent," "Very good," "Good," "Fair," and "Poor" (from the PROMIS tool).	Immediately before intervention session 1 (study day 1)
Self-rated general health, immediately after intervention session 1.	Participants will answer the question "In general, would you say your health is" with five possible ordinal answers: "Excellent," "Very good," "Good," "Fair," and "Poor" (from the PROMIS tool).	Immediately after intervention session 1 (study day 1)
Self-rated general health, immediately before intervention session 2.	Participants will answer the question "In general, would you say your health is" with five possible ordinal answers: "Excellent," "Very good," "Good," "Fair," and "Poor" (from the PROMIS tool).	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Self-rated general health, immediately after intervention session 2.	Participants will answer the question "In general, would you say your health is" with five possible ordinal answers: "Excellent," "Very good," "Good," "Fair," and "Poor" (from the PROMIS tool).	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Pain intensity, current, immediately before intervention session 1.	Participants will answer the question "What number best describes your current mid and low back pain?". Higher values represent higher levels of pain (10 = "pain as bad as you can imagine"; 0 = "no pain").	Immediately before intervention session 1 (study day 1)
Pain intensity, current, immediately after intervention session 1.	Participants will answer the question "What number best describes your current mid and low back pain?". Higher values represent higher levels of pain (10 = "pain as bad as you can imagine"; 0 = "no pain").	Immediately after intervention session 1 (study day 1)
Pain intensity, current, immediately before intervention session 2.	Participants will answer the question "What number best describes your current mid and low back pain?". Higher values represent higher levels of pain (10 = "pain as bad as you can imagine"; 0 = "no pain").	Immediately before intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Pain intensity, current, immediately after intervention session 2.	Participants will answer the question "What number best describes your current mid and low back pain?". Higher values represent higher levels of pain (10 = "pain as bad as you can imagine"; 0 = "no pain").	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Pain intensity, past week, immediately before intervention session 1.	Participants will answer the question "What number best describes your mid and low back pain on average in the past week?". Higher values represent higher levels of pain (10 = "pain as bad as you can imagine"; 0 = "no pain").	Immediately before intervention session 1 (study day 1)
Pain intensity, past week, immediately before intervention session 2.	Participants will answer the question "What number best describes your mid and low back pain on average in the past week?". Higher values represent higher levels of pain (10 = "pain as bad as you can imagine"; 0 = "no pain").	Immediately before intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Satisfaction with care, immediately after intervention session 1.	Participants will answer the question "I am satisfied with the care I received today" with five possible ordinal answers: "Strongly agree", "Agree", "Uncertain", "Disagree", "Strongly disagree" (from The Patient Satisfaction Questionnaire Short-Form [PSQ-18]).	Immediately after intervention session 1 (study day 1)
Satisfaction with care, immediately after intervention session 2.	Participants will answer the question "I am satisfied with the care I received today" with five possible ordinal answers: "Strongly agree", "Agree", "Uncertain", "Disagree", "Strongly disagree" (from The Patient Satisfaction Questionnaire Short-Form [PSQ-18]).	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Back function - self-reported flexibility, immediately before intervention session 1.	Participants will answer the question "How would you rate your back flexibility at the moment?" (adapted from The International Fitness Scale [IFIS]).	Immediately before intervention session 1 (study day 1)
Back function - self-reported flexibility, immediately after intervention session 1.	Participants will answer the question "How would you rate your back flexibility at the moment?" (adapted from The International Fitness Scale [IFIS]).	Immediately after intervention session 1 (study day 1)
Back function - self-reported flexibility, immediately before intervention session 2.	Participants will answer the question "How would you rate your back flexibility at the moment?" (adapted from The International Fitness Scale [IFIS]).	Immediately before intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Back function - self-reported flexibility, immediately after intervention session 2.	Participants will answer the question "How would you rate your back flexibility at the moment?" (adapted from The International Fitness Scale [IFIS]).	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Back function - self-reported back function, immediately before intervention session 1.	Self-reported current back function (numerical rating scale, 0 to 10). Higher values represent higher levels of back function (10 = "Best possible back function", 0 = "Worst possible back function").	Immediately before intervention session 1 (study day 1)
Back function - self-reported back function, immediately after intervention session 1.	Self-reported current back function (numerical rating scale, 0 to 10). Higher values represent higher levels of back function (10 = "Best possible back function", 0 = "Worst possible back function").	Immediately after intervention session 1 (study day 1)
Back function - self-reported back function, immediately before intervention session 2.	Self-reported current back function (numerical rating scale, 0 to 10). Higher values represent higher levels of back function (10 = "Best possible back function", 0 = "Worst possible back function").	Immediately before intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Back function - self-reported back function, immediately after intervention session 2.	Self-reported current back function (numerical rating scale, 0 to 10). Higher values represent higher levels of back function (10 = "Best possible back function", 0 = "Worst possible back function").	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Back function - self-reported ache, pain, discomfort in the mid and low back, immediately before intervention 1.	Ache, pain, discomfort in the mid and low back, by asking "During the past week, have you experienced ache, pain, discomfort in your mid and low back?" (adapted from the Cornell Musculoskeletal Discomfort Questionnaire).	Immediately before intervention session 1 (study day 1)
Back function - self-reported ache, pain, discomfort in the mid and low back, immediately before intervention 2.	Ache, pain, discomfort in the mid and low back, by asking "During the past week, have you experienced ache, pain, discomfort in your mid and low back?" (adapted from the Cornell Musculoskeletal Discomfort Questionnaire).	Immediately before intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Participant's reasons for beliefs about intervention assigned, immediately after intervention session 1.	Following the blinding assessment for the primary and secondary outcomes, participants will be asked the free text question, "Why do you believe you received this treatment?".	Immediately after intervention session 1 (study day 1)
Participant's reasons for beliefs about intervention assigned, immediately after intervention session 2.	Following the blinding assessment for the primary and secondary outcomes, participants will be asked the free text question, "Why do you believe you received this treatment?".	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Outcome assessor's reasons for beliefs about intervention assigned, immediately after intervention session 1.	Following the blinding assessment for the primary and secondary outcomes, outcome assessors will be asked the free text question, "Why do you believe this participant received this treatment?".	Immediately after intervention session 1 (study day 1)
Outcome assessor's reasons for beliefs about intervention assigned, immediately after intervention session 2.	Following the blinding assessment for the primary and secondary outcomes, outcome assessors will be asked the free text question, "Why do you believe this participant received this treatment?".	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)
Participant credibility/expectancy of active and control interventions, as measured with the credibility/expectancy questionnaire, immediately after intervention session 2.	Participants will complete the six items from the credibility/expectancy questionnaire with a hypothetical scenario: "For the following six questions, imagine that you were experiencing uncomfortable low back pain and were exposed to the treatment you received for a period of about 8 weeks." Item 1: "At this point, how logical would the SMT treatment offered to you seem?" Item 2: "At this point, how successful do you think this SMT treatment would be in reducing your symptoms?" Item 3: "How confident would you be in recommending this SMT treatment to a friend experiencing similar symptoms?" Item 4: "By the end of the SMT treatment period, how much improvement in your symptoms do you think would occur?" Item 5: "At this point, how much do you really feel that this SMT treatment would help you to reduce your symptoms?" Item 6: "By the end of the SMT period, how much improvement in your symptoms do you really feel would occur?" Higher values represent higher credibility and expectancy.	Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)

Collaborators and Investigators

• Sponsor: Balgrist University Hospital
• Collaborators: University of Zurich, Epidemiology, Biostatistics and Prevention Institute
• Investigators: Principal Investigator: Cesar A Hincapié, DC PhD, Balgrist University Hospital and University of Zurich

Study record dates

Study Major Dates

• Study Start (Actual): April 4, 2023
• Primary Completion (Actual): April 25, 2023
• Study Completion (Actual): April 25, 2023

Study Registration Dates

• First Submitted: February 27, 2023
• First Submitted That Met QC Criteria: March 19, 2023
• First Posted (Actual): March 21, 2023

Study Record Updates

• Last Update Posted (Actual): June 2, 2023
• Last Update Submitted That Met QC Criteria: June 1, 2023
• Last Verified: June 1, 2023

More Information

Terms related to this study

• Keywords: Back pain; Randomized trial; Methods; Manual therapy; Blinding assessment
• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Back Pain; Low Back Pain
• Other Study ID Numbers: SALuBRITY Blinding

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: The central contact person and principal investigator will make supporting information available upon reasonable request.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; SAP; ICF; ANALYTIC_CODE

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No